Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007). Appropriate prescribing in elderly people: how well can it be measured and optimised? The Lancet, 370(9582), 173-184. doi:10.1016/s0140-6736(07)61091-5
Wagner, E. H. (2001). Meeting the needs of chronically ill people. BMJ, 323(7319), 945-946. doi:10.1136/bmj.323.7319.945
Hoffman, C. (1996). Persons with chronic conditions. Their prevalence and costs. JAMA: The Journal of the American Medical Association, 276(18), 1473-1479. doi:10.1001/jama.276.18.1473
[+]
Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007). Appropriate prescribing in elderly people: how well can it be measured and optimised? The Lancet, 370(9582), 173-184. doi:10.1016/s0140-6736(07)61091-5
Wagner, E. H. (2001). Meeting the needs of chronically ill people. BMJ, 323(7319), 945-946. doi:10.1136/bmj.323.7319.945
Hoffman, C. (1996). Persons with chronic conditions. Their prevalence and costs. JAMA: The Journal of the American Medical Association, 276(18), 1473-1479. doi:10.1001/jama.276.18.1473
Lehnert, T., Heider, D., Leicht, H., Heinrich, S., Corrieri, S., Luppa, M., … König, H.-H. (2011). Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions. Medical Care Research and Review, 68(4), 387-420. doi:10.1177/1077558711399580
Mueller, C., Schur, C., & O’Connell, J. (1997). Prescription drug spending: the impact of age and chronic disease status. American Journal of Public Health, 87(10), 1626-1629. doi:10.2105/ajph.87.10.1626
Sambamoorthi, U., Shea, D., & Crystal, S. (2003). Total and Out-of-Pocket Expenditures for Prescription Drugs Among Older Persons. The Gerontologist, 43(3), 345-359. doi:10.1093/geront/43.3.345
Rogowski, J., Lillard, L. A., & Kington, R. (1997). The Financial Burden of Prescription Drug Use Among Elderly Persons. The Gerontologist, 37(4), 475-482. doi:10.1093/geront/37.4.475
Fahlman, C., Lynn, J., Doberman, D., Gabel, J., & Finch, M. (2006). Prescription Drug Spending for Medicare+Choice Beneficiaries in the Last Year of Life. Journal of Palliative Medicine, 9(4), 884-893. doi:10.1089/jpm.2006.9.884
Vivas, D., Guadalajara, N., Barrachina, I., Trillo, J.-L., Usó, R., & de-la-Poza, E. (2011). Explaining primary healthcare pharmacy expenditure using classification of medications for chronic conditions. Health Policy, 103(1), 9-15. doi:10.1016/j.healthpol.2011.08.014
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002). Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States. JAMA, 287(3), 337. doi:10.1001/jama.287.3.337
Fortin, M., Stewart, M., Poitras, M.-E., Almirall, J., & Maddocks, H. (2012). A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology. The Annals of Family Medicine, 10(2), 142-151. doi:10.1370/afm.1337
Rollason, V., & Vogt, N. (2003). Reduction of Polypharmacy in the Elderly. Drugs & Aging, 20(11), 817-832. doi:10.2165/00002512-200320110-00003
Bradley, M. C., Fahey, T., Cahir, C., Bennett, K., O’Reilly, D., Parsons, C., & Hughes, C. M. (2012). Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. European Journal of Clinical Pharmacology, 68(10), 1425-1433. doi:10.1007/s00228-012-1249-y
Vivas-Consuelo, D., Usó-Talamantes, R., Trillo-Mata, J. L., Caballer-Tarazona, M., Barrachina-Martínez, I., & Buigues-Pastor, L. (2014). Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups. Health Policy, 116(2-3), 188-195. doi:10.1016/j.healthpol.2014.01.012
Feinstein, A. R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases, 23(7), 455-468. doi:10.1016/0021-9681(70)90054-8
Van den Akker, M., Buntinx, F., Metsemakers, J. F. M., Roos, S., & Knottnerus, J. A. (1998). Multimorbidity in General Practice: Prevalence, Incidence, and Determinants of Co-Occurring Chronic and Recurrent Diseases. Journal of Clinical Epidemiology, 51(5), 367-375. doi:10.1016/s0895-4356(97)00306-5
Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2005). Health and Quality of Life Outcomes, 3(1), 51. doi:10.1186/1477-7525-3-51
Valderas, J. M., Starfield, B., Sibbald, B., Salisbury, C., & Roland, M. (2009). Defining Comorbidity: Implications for Understanding Health and Health Services. The Annals of Family Medicine, 7(4), 357-363. doi:10.1370/afm.983
Starfield, B. (2006). Threads and Yarns: Weaving the Tapestry of Comorbidity. The Annals of Family Medicine, 4(2), 101-103. doi:10.1370/afm.524
Diederichs, C., Berger, K., & Bartels, D. B. (2010). The Measurement of Multiple Chronic Diseases--A Systematic Review on Existing Multimorbidity Indices. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 66A(3), 301-311. doi:10.1093/gerona/glq208
Smith, S. M., Soubhi, H., Fortin, M., Hudon, C., & O’Dowd, T. (2012). Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ, 345(sep03 1), e5205-e5205. doi:10.1136/bmj.e5205
Prados-Torres, A., Calderón-Larrañaga, A., Hancco-Saavedra, J., Poblador-Plou, B., & van den Akker, M. (2014). Multimorbidity patterns: a systematic review. Journal of Clinical Epidemiology, 67(3), 254-266. doi:10.1016/j.jclinepi.2013.09.021
Bower, P., Harkness, E., Macdonald, W., Coventry, P., Bundy, C., & Moss-Morris, R. (2012). Illness representations in patients with multimorbid long-term conditions: Qualitative study. Psychology & Health, 27(10), 1211-1226. doi:10.1080/08870446.2012.662973
Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., & Ghali, W. A. (2004). New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of Clinical Epidemiology, 57(12), 1288-1294. doi:10.1016/j.jclinepi.2004.03.012
Glynn, L. G., Valderas, J. M., Healy, P., Burke, E., Newell, J., Gillespie, P., & Murphy, A. W. (2011). The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Family Practice, 28(5), 516-523. doi:10.1093/fampra/cmr013
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 380(9836), 37-43. doi:10.1016/s0140-6736(12)60240-2
Holden, L., Scuffham, P. A., Hilton, M. F., Muspratt, A., Ng, S.-K., & Whiteford, H. A. (2011). Patterns of multimorbidity in working Australians. Population Health Metrics, 9(1). doi:10.1186/1478-7954-9-15
Fortin, M., Lapointe, L., Hudon, C., Vanasse, A., Ntetu, A. L., & Maltais, D. (2004). Health and Quality of Life Outcomes, 2(1), 51. doi:10.1186/1477-7525-2-51
Schellevis, F. G., van der Velden, J., van de Lisdonk, E., van Eijk, J. T. M., & van Weel, C. (1993). Comorbidity of chronic diseases in general practice. Journal of Clinical Epidemiology, 46(5), 469-473. doi:10.1016/0895-4356(93)90024-u
Schäfer, I., Hansen, H., Schön, G., Maier, W., Höfels, S., Altiner, A., … van den Bussche, H. (2009). The German MultiCare-study: Patterns of multimorbidity in primary health care – protocol of a prospective cohort study. BMC Health Services Research, 9(1). doi:10.1186/1472-6963-9-145
Schäfer, I., von Leitner, E.-C., Schön, G., Koller, D., Hansen, H., Kolonko, T., … van den Bussche, H. (2010). Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions. PLoS ONE, 5(12), e15941. doi:10.1371/journal.pone.0015941
Van den Bussche, H., Koller, D., Kolonko, T., Hansen, H., Wegscheider, K., Glaeske, G., … Schön, G. (2011). Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health, 11(1). doi:10.1186/1471-2458-11-101
König, H.-H., Leicht, H., Bickel, H., Fuchs, A., Gensichen, J., … Eckardt, M. (2013). Effects of multiple chronic conditions on health care costs: an analysis based on an advanced tree-based regression model. BMC Health Services Research, 13(1). doi:10.1186/1472-6963-13-219
Teljeur, C., Smith, S. M., Paul, G., Kelly, A., & O’Dowd, T. (2013). Multimorbidity in a cohort of patients with type 2 diabetes. European Journal of General Practice, 19(1), 17-22. doi:10.3109/13814788.2012.714768
Poblador-Plou, B., van den Akker, M., Vos, R., Calderón-Larrañaga, A., Metsemakers, J., & Prados-Torres, A. (2014). Similar Multimorbidity Patterns in Primary Care Patients from Two European Regions: Results of a Factor Analysis. PLoS ONE, 9(6), e100375. doi:10.1371/journal.pone.0100375
Fulton, M. M., & Riley Allen, E. (2005). Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners, 17(4), 123-132. doi:10.1111/j.1041-2972.2005.0020.x
Boudreau, D. M., Yu, O., Gray, S. L., Raebel, M. A., Johnson, J., & Larson, E. B. (2011). Concomitant Use of Cholinesterase Inhibitors and Anticholinergics: Prevalence and Outcomes. Journal of the American Geriatrics Society, 59(11), 2069-2076. doi:10.1111/j.1532-5415.2011.03654.x
Veehof, L., Stewart, R., Haaijer-Ruskamp, F., & Jong, B. M. -d. (2000). The development of polypharmacy. A longitudinal study. Family Practice, 17(3), 261-267. doi:10.1093/fampra/17.3.261
Fialová, D. (2005). Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe. JAMA, 293(11), 1348. doi:10.1001/jama.293.11.1348
Bjerrum, L., Rosholm, J. U., Hallas, J., & Kragstrup, J. (1997). Methods for estimating the occurrence of polypharmacy by means of a prescription database. European Journal of Clinical Pharmacology, 53(1), 7-11. doi:10.1007/s002280050329
Moen, J., Antonov, K., Larsson, C. A., Lindblad, U., Nilsson, J. L. G., Råstam, L., & Ring, L. (2009). Factors Associated with Multiple Medication Use in Different Age Groups. Annals of Pharmacotherapy, 43(12), 1978-1985. doi:10.1345/aph.1m354
Orueta Sánchez, R., Santos Rodríguez, C., González Hidalgo, E., Fagundo Becerra, E. M., Alejandre Lázaro, G., Carmona de la Morena, J., … Butrón Gómez, T. (2011). Medicalización de la vida (I). Revista Clínica de Medicina de Familia, 4(2). doi:10.4321/s1699-695x2011000200011
Onder, G., Petrovic, M., Tangiisuran, B., Meinardi, M. C., Markito-Notenboom, W. P., Somers, A., … van der Cammen, T. J. M. (2010). Development and Validation of a Score to Assess Risk of Adverse Drug Reactions Among In-Hospital Patients 65 Years or Older. Archives of Internal Medicine, 170(13). doi:10.1001/archinternmed.2010.153
Onder, G., Liperoti, R., Fialova, D., Topinkova, E., Tosato, M., … Danese, P. (2012). Polypharmacy in Nursing Home in Europe: Results From the SHELTER Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 67A(6), 698-704. doi:10.1093/gerona/glr233
Hanlon, J. T., Schmader, K. E., Koronkowski, M. J., Weinberger, M., Landsman, P. B., Samsa, G. P., & Lewis, I. K. (1997). Adverse Drug Events In High Risk Older Outpatients. Journal of the American Geriatrics Society, 45(8), 945-948. doi:10.1111/j.1532-5415.1997.tb02964.x
Suelves, J. M., Martínez, V., & Medina, A. (2010). Lesiones por caídas y factores asociados en personas mayores de Cataluña, España. Revista Panamericana de Salud Pública, 27(1), 37-42. doi:10.1590/s1020-49892010000100006
Klarin, I., Wimo, A., & Fastbom, J. (2005). The Association of Inappropriate Drug Use with Hospitalisation and Mortality. Drugs & Aging, 22(1), 69-82. doi:10.2165/00002512-200522010-00005
Incalzi, A. R., Capparella, O., Gemma, A., Porcedda, P., Raccis, G., Sommella, L., & Carbonin, P. U. (1992). A Simple Method of Recognizing Geriatric Patients at Risk for Death and Disability. Journal of the American Geriatrics Society, 40(1), 34-38. doi:10.1111/j.1532-5415.1992.tb01826.x
Campbell, S. E., Seymour, D. G., & Primrose, W. R. (2004). A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age and Ageing, 33(2), 110-115. doi:10.1093/ageing/afh036
Sotoca Momblona, J. M., Canivell Fusté, S., Alemany Vilches, L., Sisó Almirall, A., Codina Jané, C., & Ribas Sala, J. (2009). Problemas relacionados con la medicación que causan ingresos hospitalarios. Atención Primaria, 41(3), 141-146. doi:10.1016/j.aprim.2008.07.002
Martín Martínez, M. A., Alférez, R. C., Escortell Mayor, E., Rico Blázquez, M., & Sarría Santamera, A. (2011). Factores asociados a reingresos hospitalarios en pacientes de edad avanzada. Atención Primaria, 43(3), 117-124. doi:10.1016/j.aprim.2009.12.007
Kaur, S., Mitchell, G., Vitetta, L., & Roberts, M. S. (2009). Interventions that can Reduce Inappropriate Prescribing in the Elderly. Drugs & Aging, 26(12), 1013-1028. doi:10.2165/11318890-000000000-00000
Shojania, K. G., & Grimshaw, J. M. (2005). Evidence-Based Quality Improvement: The State Of The Science. Health Affairs, 24(1), 138-150. doi:10.1377/hlthaff.24.1.138
Mossey, J. M., & Roos, L. L. (1987). Using insurance claims to measure health status: The illness scale. Journal of Chronic Diseases, 40, 41S-50S. doi:10.1016/s0021-9681(87)80031-0
Von Korff, M., Wagner, E. H., & Saunders, K. (1992). A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology, 45(2), 197-203. doi:10.1016/0895-4356(92)90016-g
Malone, D. C., Billups, S. J., Valuck, R. J., & Carter, B. L. (1999). Development of a Chronic Disease Indicator Score Using a Veterans Affairs Medical Center Medication Database. Journal of Clinical Epidemiology, 52(6), 551-557. doi:10.1016/s0895-4356(99)00029-3
Clark, D. O., Korff, M. V., Saunders, K., Balugh, W. M., & Simon, G. E. (1995). A Chronic Disease Score with Empirically Derived Weights. Medical Care, 33(8), 783-795. doi:10.1097/00005650-199508000-00004
Lamers, L. M. (1999). Pharmacy Costs Groups. Medical Care, 37(8), 824-830. doi:10.1097/00005650-199908000-00012
Lamers, L. M. (2001). Health-Based Risk Adjustment: Is Inpatient and Outpatient Diagnostic Information Sufficient? Inquiry, 38(4), 423-431. doi:10.5034/inquiryjrnl_38.4.423
Lamers, L. M., & van Vliet, R. C. J. A. (2004). The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy, 68(1), 113-121. doi:10.1016/j.healthpol.2003.09.001
Lamers, L. M., & Vliet, R. C. J. A. (2003). Health-based risk adjustment Improving the pharmacy-based cost group. The European Journal of Health Economics, 4(2), 107-114. doi:10.1007/s10198-002-0159-9
Johnson, R. E., Hornbrook, M. C., & Nichols, G. A. (1994). Replicating the chronic disease score (CDS) from automated pharmacy data. Journal of Clinical Epidemiology, 47(10), 1191-1199. doi:10.1016/0895-4356(94)90106-6
Stam, P. J. A., van Vliet, R. C. J. A., & van de Ven, W. P. M. M. (2010). Diagnostic, Pharmacy-Based, and Self-Reported Health Measures in Risk Equalization Models. Medical Care, 48(5), 448-457. doi:10.1097/mlr.0b013e3181d559b4
Weiner, J. P., Starfield, B. H., Steinwachs, D. M., & Mumford, L. M. (1991). Development and Application of a Population-Oriented Measure of Ambulatory Care Case-Mix. Medical Care, 29(5), 452-472. doi:10.1097/00005650-199105000-00006
Hughes, J. S., Averill, R. F., Eisenhandler, J., Goldfield, N. I., Muldoon, J., Neff, J. M., & Gay, J. C. (2004). Clinical Risk Groups (CRGs). Medical Care, 42(1), 81-90. doi:10.1097/01.mlr.0000102367.93252.70
García-Goñi, M., & Ibern, P. (2007). Predictability of drug expenditures: an application using morbidity data. Health Economics, 17(1), 119-126. doi:10.1002/hec.1238
García-Goñi, M., Ibern, P., & Inoriza, J. M. (2008). Hybrid risk adjustment for pharmaceutical benefits. The European Journal of Health Economics, 10(3), 299-308. doi:10.1007/s10198-008-0133-2
Hanley, G. E., Morgan, S., & Reid, R. J. (2010). Explaining Prescription Drug Use and Expenditures Using the Adjusted Clinical Groups Case-Mix System in the Population of British Columbia, Canada. Medical Care, 48(5), 402-408. doi:10.1097/mlr.0b013e3181ca3d5d
Buchner, F., Goepffarth, D., & Wasem, J. (2013). The new risk adjustment formula in Germany: Implementation and first experiences. Health Policy, 109(3), 253-262. doi:10.1016/j.healthpol.2012.12.001
Vivas-Consuelo, D., Usó-Talamantes, R., Guadalajara-Olmeda, N., Trillo-Mata, J.-L., Sancho-Mestre, C., & Buigues-Pastor, L. (2014). Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool. BMC Health Services Research, 14(1). doi:10.1186/1472-6963-14-462
Lane, C. J., Bronskill, S. E., Sykora, K., Dhalla, I. A., Anderson, G. M., Mamdani, M. M., … Rochon, P. A. (2004). Potentially Inappropriate Prescribing in Ontario Community-Dwelling Older Adults and Nursing Home Residents. Journal of the American Geriatrics Society, 52(6), 861-866. doi:10.1111/j.1532-5415.2004.52250.x
King, M. A., & Roberts, M. S. (2007). The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes. Pharmacy World & Science, 29(1), 39-42. doi:10.1007/s11096-005-5618-9
Bradley, M. C., Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T., Fahey, T., & Hughes, C. M. (2014). Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatrics, 14(1). doi:10.1186/1471-2318-14-72
Dalleur, O., Boland, B., Losseau, C., Henrard, S., Wouters, D., Speybroeck, N., … Spinewine, A. (2014). Reduction of Potentially Inappropriate Medications Using the STOPP Criteria in Frail Older Inpatients: A Randomised Controlled Study. Drugs & Aging, 31(4), 291-298. doi:10.1007/s40266-014-0157-5
Wessell, A. M., Nietert, P. J., Jenkins, R. G., Nemeth, L. S., & Ornstein, S. M. (2008). Inappropriate medication use in the elderly: Results from a quality improvement project in 99 primary care practices. The American Journal of Geriatric Pharmacotherapy, 6(1), 21-27. doi:10.1016/j.amjopharm.2008.02.001
Beers, M. H. (1991). Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents. Archives of Internal Medicine, 151(9), 1825. doi:10.1001/archinte.1991.00400090107019
Knight, E. L. (2001). Quality Indicators for Appropriate Medication Use in Vulnerable Elders. Annals of Internal Medicine, 135(8_Part_2), 703. doi:10.7326/0003-4819-135-8_part_2-200110161-00009
Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003). Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Archives of Internal Medicine, 163(22), 2716. doi:10.1001/archinte.163.22.2716
Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & O Mahony, D. (2008). STOPP (Screening Tool of Older Person s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int. Journal of Clinical Pharmacology and Therapeutics, 46(02), 72-83. doi:10.5414/cpp46072
Delgado Silveira, E., Muñoz García, M., Montero Errasquin, B., Sánchez Castellano, C., Gallagher, P. F., & Cruz-Jentoft, A. J. (2009). Prescripción inapropiada de medicamentos en los pacientes mayores: los criterios STOPP/START. Revista Española de Geriatría y Gerontología, 44(5), 273-279. doi:10.1016/j.regg.2009.03.017
Barry, P. J., Gallagher, P., Ryan, C., & O’mahony, D. (2007). START (screening tool to alert doctors to the right treatment) an evidence-based screening tool to detect prescribing omissions in elderly patients. Age and Ageing, 36(6), 632-638. doi:10.1093/ageing/afm118
Wenger, N. S. (2001). Assessing Care of Vulnerable Elders: ACOVE Project Overview. Annals of Internal Medicine, 135(8_Part_2), 642. doi:10.7326/0003-4819-135-8_part_2-200110161-00002
Fick, D. M., Mion, L. C., Beers, M. H., & L. Waller, J. (2008). Health outcomes associated with potentially inappropriate medication use in older adults. Research in Nursing & Health, 31(1), 42-51. doi:10.1002/nur.20232
Clyne, B., Bradley, M. C., Hughes, C., Fahey, T., & Lapane, K. L. (2012). Electronic Prescribing and Other Forms of Technology to Reduce Inappropriate Medication Use and Polypharmacy in Older People: A Review of Current Evidence. Clinics in Geriatric Medicine, 28(2), 301-322. doi:10.1016/j.cger.2012.01.009
Curtain, C., & Peterson, G. M. (2014). Review of computerized clinical decision support in community pharmacy. Journal of Clinical Pharmacy and Therapeutics, 39(4), 343-348. doi:10.1111/jcpt.12168
Raebel, M. A., Charles, J., Dugan, J., Carroll, N. M., Korner, E. J., Brand, D. W., & Magid, D. J. (2007). Randomized Trial to Improve Prescribing Safety in Ambulatory Elderly Patients. Journal of the American Geriatrics Society, 55(7), 977-985. doi:10.1111/j.1532-5415.2007.01202.x
Crotty, M., Rowett, D., Spurling, L., Giles, L. C., & Phillips, P. A. (2004). Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. The American Journal of Geriatric Pharmacotherapy, 2(4), 257-264. doi:10.1016/j.amjopharm.2005.01.001
Clyne, B., Bradley, M. C., Smith, S. M., Hughes, C. M., Motterlini, N., … Clear, D. (2013). Effectiveness of medicines review with web-based pharmaceutical treatment algorithms in reducing potentially inappropriate prescribing in older people in primary care: a cluster randomized trial (OPTI-SCRIPT study protocol). Trials, 14(1), 72. doi:10.1186/1745-6215-14-72
Hanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., … Feussner, J. R. (1996). A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. The American Journal of Medicine, 100(4), 428-437. doi:10.1016/s0002-9343(97)89519-8
Krska, J. (2001). Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age and Ageing, 30(3), 205-211. doi:10.1093/ageing/30.3.205
Saltvedt, I., Spigset, O., Ruths, S., Fayers, P., Kaasa, S., & Sletvold, O. (2005). Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. European Journal of Clinical Pharmacology, 61(12), 921-928. doi:10.1007/s00228-005-0046-2
Meredith, S., Feldman, P., Frey, D., Giammarco, L., Hall, K., Arnold, K., … Ray, W. A. (2002). Improving Medication Use in Newly Admitted Home Healthcare Patients: A Randomized Controlled Trial. Journal of the American Geriatrics Society, 50(9), 1484-1491. doi:10.1046/j.1532-5415.2002.50402.x
Kim, J., Ahn, B.-J., Chae, H.-S., Han, S., Doh, K., Choi, J., … Yim, D.-S. (2011). A Population Pharmacokinetic-Pharmacodynamic Model for Simvastatin that Predicts Low-Density Lipoprotein-Cholesterol Reduction in Patients with Primary Hyperlipidaemia. Basic & Clinical Pharmacology & Toxicology, 109(3), 156-163. doi:10.1111/j.1742-7843.2011.00700.x
Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2014). Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. British Journal of Clinical Pharmacology, 78(4), 738-747. doi:10.1111/bcp.12386
Zermansky, A. G., Alldred, D. P., Petty, D. R., Raynor, D. K., Freemantle, N., Eastaugh, J., & Bowie, P. (2006). Clinical medication review by a pharmacist of elderly people living in care homes—randomised controlled trial. Age and Ageing, 35(6), 586-591. doi:10.1093/ageing/afl075
Salisbury, C. (2013). Multimorbidity: time for action rather than words. British Journal of General Practice, 63(607), 64-65. doi:10.3399/bjgp13x661020
Roland, M., & Paddison, C. (2013). Better management of patients with multimorbidity. BMJ, 346(may02 1), f2510-f2510. doi:10.1136/bmj.f2510
Ammenwerth, E., Duftschmid, G., Gall, W., Hackl, W. O., Hoerbst, A., Janzek-Hawlat, S., … Dorda, W. (2014). A nationwide computerized patient medication history: Evaluation of the Austrian pilot project «e-Medikation». International Journal of Medical Informatics, 83(9), 655-669. doi:10.1016/j.ijmedinf.2014.06.004
[-]
![[Cerrado]](/themes/UPV/images/candado.png)
